Your browser doesn't support javascript.
loading
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing-off of erenumab within monthly treatment cycle.
Dodick, David W; Blumenfeld, Andrew M; Halker Singh, Rashmi B; Williams, Rachel; Zhang, Feng; Chen, Po-Wei; Hsu, Cheng-Pang; Peng, Cheng; Snellman, Josefin; Chehrenama, Mahan; Ailani, Jessica.
Affiliation
  • Dodick DW; Department of Neurology, Mayo Clinic, Phoenix, Arizona, USA.
  • Blumenfeld AM; The Headache Center of Southern California, The Neurology Center, Carlsbad, California, USA.
  • Halker Singh RB; Department of Neurology, Mayo Clinic, Phoenix, Arizona, USA.
  • Williams R; Amgen Inc., Thousand Oaks, California, USA.
  • Zhang F; Amgen Inc., Thousand Oaks, California, USA.
  • Chen PW; Amgen Inc., Thousand Oaks, California, USA.
  • Hsu CP; Amgen Inc., Thousand Oaks, California, USA.
  • Peng C; Amgen Inc., Thousand Oaks, California, USA.
  • Snellman J; Novartis Pharma AG, Basel, Switzerland.
  • Chehrenama M; Amgen Inc., Thousand Oaks, California, USA.
  • Ailani J; Department of Neurology, MedStar Georgetown University Hospital, Washington, District of Columbia, USA.
Headache ; 63(2): 233-242, 2023 02.
Article in En | MEDLINE | ID: mdl-36226464
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcitonin Gene-Related Peptide Receptor Antagonists / Migraine Disorders Type of study: Clinical_trials Limits: Humans Language: En Journal: Headache Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcitonin Gene-Related Peptide Receptor Antagonists / Migraine Disorders Type of study: Clinical_trials Limits: Humans Language: En Journal: Headache Year: 2023 Type: Article Affiliation country: United States